You are here:
As a public-private partnership including civil society, the Vaccine Alliance plays a catalytic role providing funding to countries and demonstrates "added-value" by:
Gavi Strategy 2011-2015: Business plan
Gavi Strategy & Business Plan
Approximately six million future deaths averted from hepatitis B, Haemophilus influenzae type B, measles, pertussis, pneumococcal disease, polio, rotavirus diarrhoea and yellow fever since Gavi's launch in 2000.
© Gavi 2014
modal window here